CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | O'Grady Brendan P. EVP, North America Commercial | Sale | −9,849 | $10.83 | $107K | 93,231.49 |
| 2021-03-01 | O'Grady Brendan P. EVP, North America Commercial | Sale | −63,278 | $10.93 | $691K | 29,953.49 |
| 2021-03-01 | Nazzi Gianfranco EVP, International Markets | Sale | −15,177 | $10.85 | $165K | 60,410.36 |
| 2021-03-01 | Nazzi Gianfranco EVP, International Markets | Sale | −60,410.36 | $10.88 | $657K | 0 |
| 2021-03-01 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −10,912 | $10.83 | $118K | 114,063.51 |
| 2021-03-01 | Drape Eric Executive VP Global Operations | Sale | −9,795 | $10.85 | $106K | 49,291 |
| 2021-03-01 | Dethlefs Sven EVP Global Marketing&Portfolio | Sale | −7,486 | $10.83 | $81K | 69,263.7 |
| 2021-03-01 | Daniell Richard Exec. VP, European Commercial | Sale | −20,598 | $10.85 | $224K | 10,765 |
| 2021-02-28 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +18,430 | 21,404.39 | ||
| 2021-02-28 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −18,430 | 55,290 | ||
| 2021-02-28 | Schultz Kare President and CEO | Option exercise | +65,047 | 800,881 | ||
| 2021-02-28 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −65,047 | 195,143 | ||
| 2021-02-28 | Sabag Mark See "Remarks" below | Option exercise | +20,598 | 131,922 | ||
| 2021-02-28 | Sabag Mark See "Remarks" below | Option exercise · Restricted Share Units | −20,598 | 61,795 | ||
| 2021-02-28 | O'Grady Brendan P. EVP, North America Commercial | Option exercise | +24,934 | 103,080.49 | ||
| 2021-02-28 | O'Grady Brendan P. EVP, North America Commercial | Option exercise · Restricted Share Units | −24,934 | 74,805 | ||
| 2021-02-28 | Nazzi Gianfranco EVP, International Markets | Option exercise | +15,177 | 75,587.36 | ||
| 2021-02-28 | Nazzi Gianfranco EVP, International Markets | Option exercise · Restricted Share Units | −15,177 | 45,534 | ||
| 2021-02-28 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +18,430 | 18,430 | ||
| 2021-02-28 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −18,430 | 55,290 |
Page 49 of 76 · 1,517 trades